Investor Overview

TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy ® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its flagship Hi·Art ® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD ™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile ™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.


More
Active Webcasts
Webcast ImageWebcast
TomoTherapy Incorporated at Needham & Company 12th Annual Growth Conference (Replay)
01/14/10 at 1:10 p.m. ET
Webcast ImageWebcast
Q4 2009 TomoTherapy Incorporated Earnings Conference Call (Live)
02/17/10 at 4:00 p.m. CT
Recent NewsRSS RSS Feeds | More
DateTitle 
02/05/10TomoTherapy to Announce Fourth-Quarter Results on Wednesday, February 17, 2010
MADISON, WI, Feb 05, 2010 (MARKETWIRE via COMTEX) -- TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that it will release its 2009 fourth-quarter results on Wednesday, February 17, 2010 at 3:00 p.m. CT. TomoTherapy will hold an investment community conference call on Wednesday, February 17, 2010 beginning at 4:00 p.m. CT. Fred Robertson, M.D., CEO, and Thomas Powell, CFO, will review fourth-quarter performance and... 
Printer Friendly Version
02/02/10Addenbrooke's Hospital Begins Treating Patients on Second TomoTherapy(R) Cancer Treatment System
Expanded Capacity Provides Cambridge, England-Based Hospital With Ability to Treat More Patients With Advanced Image-Guided IMRTMADISON, WI, Feb 02, 2010 (MARKETWIRE via COMTEX) -- TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that Addenbrooke's Hospital, which is run by the Cambridge University Hospitals National Health Service (NHS) Foundation Trust, recently installed and began treating patients on its second Tom... 
Printer Friendly Version
01/11/10TomoTherapy to Present at Needham Growth Stock Conference
MADISON, WI, Jan 11, 2010 (MARKETWIRE via COMTEX) -- TomoTherapy Incorporated (NASDAQ: TOMO) today announced that Dr. Fred Robertson, CEO, and Thomas Powell, CFO, will present at the 12th Annual Needham Growth Stock Conference on Thursday, January 14, 2010 at 1:10 p.m. ET. The conference is scheduled for January 12-14 at The New York Palace in New York City, N.Y. A live Webcast of the presentation will be available on the investor relations page of TomoTherapy.com. For those who are un... 
Printer Friendly Version
12/08/09TomoTherapy Partners With Monmouth Medical Center to Train Radiation Oncologists in Use of Advanced Radiation Therapy Technology
MADISON, WI, Dec 08, 2009 (MARKETWIRE via COMTEX) -- TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it has expanded its Institute of Learning curriculum to include a course for radiation oncologists. The course, which is being offered in partnership with Monmouth Medical Center of Long Branch, N.J., is designed to introduce physicians to the fundamentals of the TomoTherapy(R) platform and its use in a clinical setting. The radiation oncologist course on TomoTherapy technology... 
Printer Friendly Version
Upcoming EventsMore
DateTitle
02/17/10 4:00 p.m. CT
Q4 2009 TomoTherapy Incorporated Earnings Conference Call
Featured ReportMore
There are currently no items available.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Printer Friendly Version Print Page | E-mail this page E-mail Page | RSS RSS Feeds | E-mail Alerts E-mail Alerts | Download Financial Tear Sheet Tear Sheet